1. Home
  2. NXJ vs BVS Comparison

NXJ vs BVS Comparison

Compare NXJ & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXJ
  • BVS
  • Stock Information
  • Founded
  • NXJ 1999
  • BVS 2011
  • Country
  • NXJ United States
  • BVS United States
  • Employees
  • NXJ N/A
  • BVS N/A
  • Industry
  • NXJ Finance/Investors Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NXJ Finance
  • BVS Health Care
  • Exchange
  • NXJ Nasdaq
  • BVS Nasdaq
  • Market Cap
  • NXJ 457.7M
  • BVS 432.7M
  • IPO Year
  • NXJ N/A
  • BVS 2021
  • Fundamental
  • Price
  • NXJ $12.10
  • BVS $7.28
  • Analyst Decision
  • NXJ
  • BVS Strong Buy
  • Analyst Count
  • NXJ 0
  • BVS 5
  • Target Price
  • NXJ N/A
  • BVS $14.40
  • AVG Volume (30 Days)
  • NXJ 74.9K
  • BVS 391.4K
  • Earning Date
  • NXJ 01-01-0001
  • BVS 11-04-2025
  • Dividend Yield
  • NXJ 3.27%
  • BVS N/A
  • EPS Growth
  • NXJ N/A
  • BVS N/A
  • EPS
  • NXJ N/A
  • BVS 0.03
  • Revenue
  • NXJ N/A
  • BVS $564,142,000.00
  • Revenue This Year
  • NXJ N/A
  • BVS N/A
  • Revenue Next Year
  • NXJ N/A
  • BVS $6.84
  • P/E Ratio
  • NXJ N/A
  • BVS $252.78
  • Revenue Growth
  • NXJ N/A
  • BVS 5.08
  • 52 Week Low
  • NXJ $10.06
  • BVS $5.81
  • 52 Week High
  • NXJ $12.24
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • NXJ 80.79
  • BVS 53.16
  • Support Level
  • NXJ $11.12
  • BVS $6.98
  • Resistance Level
  • NXJ $11.37
  • BVS $7.41
  • Average True Range (ATR)
  • NXJ 0.10
  • BVS 0.31
  • MACD
  • NXJ 0.08
  • BVS -0.04
  • Stochastic Oscillator
  • NXJ 98.35
  • BVS 39.47

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: